|
US4599152A
(en)
|
1985-05-24 |
1986-07-08 |
Albion Laboratories |
Pure amino acid chelates
|
|
US4863898A
(en)
|
1986-02-06 |
1989-09-05 |
Albion International, Inc. |
Amino acid chelated compositions for delivery to specific biological tissue sites
|
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
|
US4804539A
(en)
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
US4914088A
(en)
|
1987-04-02 |
1990-04-03 |
Thomas Glonek |
Dry eye treatment solution and method
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
US5061815A
(en)
|
1988-07-06 |
1991-10-29 |
Zinpro Corporation |
Metal lysine complexes and method for producing metal lysine complexes
|
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
|
ZA912797B
(en)
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
|
DE69115990T2
(de)
|
1990-05-29 |
1996-05-30 |
Ocular Res Of Bonton Inc |
Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
|
|
ZA927277B
(en)
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
US6048897A
(en)
|
1993-06-15 |
2000-04-11 |
Brigham And Women's Hospital |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
US6887901B1
(en)
|
1993-06-15 |
2005-05-03 |
Brigham & Women's Hospital, Inc. |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
US5441951A
(en)
|
1994-06-15 |
1995-08-15 |
Brigham & Women's Hospital |
Lipoxin compounds
|
|
IT1264987B1
(it)
|
1993-12-14 |
1996-10-17 |
Prospa Bv |
Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
FR2774591B1
(fr)
|
1998-02-12 |
2000-05-05 |
Lipha |
Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
|
|
US6517870B1
(en)
|
1998-04-29 |
2003-02-11 |
Sumitomo Pharmaceuticals Company, Limited |
Oral formulation comprising biguanide and an organic acid
|
|
JP4526622B2
(ja)
|
1998-10-23 |
2010-08-18 |
北興化学工業株式会社 |
農園芸用種子消毒剤および種子の消毒方法
|
|
JP2000212145A
(ja)
|
1999-01-22 |
2000-08-02 |
Hokko Chem Ind Co Ltd |
Ｎε―アシル―４―オキサリジンおよびその製造用中間体
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
US7105572B2
(en)
|
2000-02-04 |
2006-09-12 |
Takeda Pharmaceutical Company Limited |
Stable emulsion compositions
|
|
JP4932116B2
(ja)
|
2000-02-16 |
2012-05-16 |
ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド |
アスピリン誘発脂質メディエータ
|
|
US6491950B1
(en)
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
|
US6667064B2
(en)
|
2000-08-30 |
2003-12-23 |
Pilot Therapeutics, Inc. |
Composition and method for treatment of hypertriglyceridemia
|
|
US6689385B2
(en)
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
|
DE10102050A1
(de)
|
2001-01-17 |
2002-07-18 |
Basf Ag |
Zubereitung zur Verbesserung der Nahrungsverwertung
|
|
PT1406698E
(pt)
|
2001-03-02 |
2009-01-12 |
Brigham & Womens Hospital |
Análogos de lipoxina como novos inibidores da angiogénese
|
|
CA2442106A1
(en)
|
2001-03-29 |
2002-10-10 |
Basf Aktiengesellschaft |
Conjugated unsaturated glyceride mixtures and a method for producing the same
|
|
EP1429602B1
(en)
|
2001-08-31 |
2009-12-16 |
Rutgers, The State University Of New Jersey |
Methods for treating disorders using plant extracts
|
|
JP4652685B2
(ja)
|
2001-11-06 |
2011-03-16 |
ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド |
喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物
|
|
ITMI20012384A1
(it)
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
|
AU2003211131A1
(en)
|
2002-02-14 |
2003-09-04 |
Sonus Pharmaceuticals, Inc. |
Metformin salts of lipophilic acids
|
|
US7670612B2
(en)
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
WO2003093449A2
(en)
|
2002-05-06 |
2003-11-13 |
Nucleonics, Inc. |
Methods for delivery of nucleic acids
|
|
JP2005529945A
(ja)
|
2002-06-17 |
2005-10-06 |
リソルヴィックス ファーマシューティカルズ |
オメガ−３ｐｕｆａ由来の脂質メディエーターの類似体及び使用方法
|
|
JP4694207B2
(ja)
|
2002-07-05 |
2011-06-08 |
コルジウム ファーマシューティカル， インコーポレイテッド |
オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
|
|
AU2003261298A1
(en)
|
2002-08-02 |
2004-02-23 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
EP2384750A1
(en)
|
2002-09-27 |
2011-11-09 |
Martek Biosciences Corporation |
Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
|
|
US7547454B2
(en)
|
2002-11-07 |
2009-06-16 |
Shyam K Gupta |
Hydroxy acid complexes for antiaging and skin renovation
|
|
JP2004175790A
(ja)
|
2002-11-12 |
2004-06-24 |
Arita Junichi |
α−グルコシダーゼ阻害作用を有する亜鉛含有物
|
|
ITMI20022394A1
(it)
|
2002-11-13 |
2004-05-14 |
Bracco Spa |
Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
|
|
JP2006520335A
(ja)
|
2003-03-18 |
2006-09-07 |
ノバルティス アクチエンゲゼルシャフト |
脂肪酸とアミノ酸を含有する組成物
|
|
EP1624858B1
(en)
|
2003-04-09 |
2018-06-06 |
Rutgers, the State University of New Jersey |
Novel encochleation methods
|
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
BRPI0415858A
(pt)
|
2003-10-29 |
2007-01-09 |
Sonus Pharma Inc |
compostos de medicamentos terapêuticos modificados por tocoferol
|
|
EP1677759A1
(en)
|
2003-10-31 |
2006-07-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
|
|
AU2005205882A1
(en)
|
2004-01-22 |
2005-08-04 |
Neurosearch A/S |
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
|
|
GB0403247D0
(en)
|
2004-02-13 |
2004-03-17 |
Tillotts Pharma Ag |
A pharmaceutical composition
|
|
EP1591114A1
(en)
|
2004-03-12 |
2005-11-02 |
Fournier Laboratories Ireland Limited |
Use of metformin and orlistat for the treatment or prevention of obesity
|
|
US20060003976A1
(en)
|
2004-06-04 |
2006-01-05 |
Yuehua Zhang |
Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds
|
|
TWI236573B
(en)
|
2004-07-09 |
2005-07-21 |
Asia Optical Co Inc |
Camera lens with adjustment mechanism
|
|
CN101094683A
(zh)
|
2004-10-29 |
2007-12-26 |
J·坎贝尔－托夫特 |
从催吐萝芙木和酸橙中分离的抗糖尿病提取物及其使用方法
|
|
US20060293288A1
(en)
*
|
2005-01-07 |
2006-12-28 |
Serhan Charles N |
Use of resolvins to treat gastrointestinal diseases
|
|
JP2008540394A
(ja)
|
2005-05-04 |
2008-11-20 |
プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ |
脂肪酸組成物、即ち、ｄｈａ誘導体の医薬としての使用
|
|
CA2613875C
(en)
|
2005-07-04 |
2018-09-25 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
|
US8273792B2
(en)
*
|
2005-10-03 |
2012-09-25 |
The Brigham And Women's Hospital, Inc. |
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
|
|
US7666898B2
(en)
|
2005-11-03 |
2010-02-23 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors
|
|
US20100121048A1
(en)
|
2006-02-16 |
2010-05-13 |
Takanobu Kuroita |
Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension
|
|
US20090047340A1
(en)
|
2006-03-29 |
2009-02-19 |
Guilford F Timothy |
Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
|
|
CN101522658A
(zh)
|
2006-06-16 |
2009-09-02 |
因迪基恩药物公司 |
作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐
|
|
US20120189569A1
(en)
|
2006-08-06 |
2012-07-26 |
Bioderm Research |
Hydroxy Acid Complexes for Skin Renovation and Clarity
|
|
TW200816991A
(en)
*
|
2006-08-23 |
2008-04-16 |
Bayer Schering Pharma Ag |
Treatment and prevention of intestinal fibrosis
|
|
KR101438177B1
(ko)
|
2006-11-01 |
2014-09-05 |
프로노바 바이오파마 너지 에이에스 |
페록시솜 증식자-활성화 수용체의 활성자 또는 조절자인 알파-치환된 오메가-3 지질
|
|
US20100105773A1
(en)
|
2006-11-09 |
2010-04-29 |
The Children's Medical Center Corporation |
Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization
|
|
PE20120395A1
(es)
*
|
2006-12-04 |
2012-05-23 |
Bayer Ip Gmbh |
Sal de potasio cristalina de analogos de lipoxina a4
|
|
CN105152983A
(zh)
|
2007-01-29 |
2015-12-16 |
韩诺生物制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
|
US20090227560A1
(en)
|
2007-04-27 |
2009-09-10 |
Takanobu Kuroita |
Substituted imidazole compound and use thereof
|
|
TW200904433A
(en)
|
2007-04-27 |
2009-02-01 |
Takeda Pharmaceutical |
Substituted imidazole compound and use thereof
|
|
US20090054513A1
(en)
|
2007-08-22 |
2009-02-26 |
Response Scientific, Inc. |
Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
|
|
CN101855204B
(zh)
|
2007-09-21 |
2013-09-11 |
韩兀生物制药株式会社 |
N,n-二甲基亚氨二羰酸二酰胺二羧酸盐、其制备方法及其药物组合物
|
|
JP5441705B2
(ja)
|
2007-10-15 |
2014-03-12 |
武田薬品工業株式会社 |
アミド化合物およびその用途
|
|
CN105903005A
(zh)
|
2008-05-05 |
2016-08-31 |
奥拉姆德有限公司 |
用于口服给予艾塞那肽的方法和组合物
|
|
CN102123990B
(zh)
|
2008-06-19 |
2014-07-09 |
武田药品工业株式会社 |
杂环化合物及其用途
|
|
CN102159539B
(zh)
|
2008-06-26 |
2014-04-16 |
矽烷实验室股份公司 |
用于血糖控制的新型二甲双胍甘氨酸盐
|
|
FR2934519B1
(fr)
|
2008-08-01 |
2013-06-28 |
Oreal |
Procede de fabrication d'un premier recipient de produit cosmetique, moule, col et recipient associes
|
|
NZ624963A
(en)
|
2009-04-29 |
2016-07-29 |
Amarin Pharmaceuticals Ie Ltd |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
|
EP3318255B1
(en)
|
2009-06-15 |
2021-03-10 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating stroke in a subject on concomitant statin therapy
|
|
WO2011034887A2
(en)
|
2009-09-15 |
2011-03-24 |
The Brigham And Women's Hospital, Inc. |
A method for treating neuropathic pain
|
|
PL217815B1
(pl)
|
2009-12-14 |
2014-08-29 |
Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością |
Napój izotoniczny z chelatami
|
|
US8178707B2
(en)
|
2010-03-25 |
2012-05-15 |
Jost Chemical Company |
Co-precipitated salts of fatty acids
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
|
US20120178813A1
(en)
|
2011-01-12 |
2012-07-12 |
Thetis Pharmaceuticals Llc |
Lipid-lowering antidiabetic agent
|
|
EP2705844B1
(en)
|
2011-04-13 |
2019-05-22 |
Ajinomoto Co., Inc. |
Nutritional composition
|
|
UA114615C2
(uk)
|
2012-01-06 |
2017-07-10 |
Омтера Фармасьютікалз, Інк. |
Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти
|
|
JP2015511012A
(ja)
|
2012-03-06 |
2015-04-13 |
ライフ テクノロジーズ コーポレーション |
全身性エリテマトーデスのためのバイオマーカー
|
|
DK2858496T3
(da)
|
2012-05-10 |
2023-07-24 |
Solutex Na Llc |
Olier med anti-inflammatorisk aktivitet, som indeholder naturlige specialiserede pro-afhjælpningsmediatorer og deres forløbere
|
|
WO2013192109A1
(en)
|
2012-06-17 |
2013-12-27 |
Matinas Biopharma, Inc. |
Omega-3 pentaenoic acid compositions and methods of use
|
|
US20140011814A1
(en)
|
2012-07-06 |
2014-01-09 |
Thetis Pharmaceuticals Llc |
Diamine and meglumine salt forms of fatty acids
|
|
US8765811B2
(en)
|
2012-07-10 |
2014-07-01 |
Thetis Pharmaceuticals Llc |
Tri-salt form of metformin
|
|
EP2872483A4
(en)
|
2012-07-10 |
2016-03-16 |
Thetis Pharmaceuticals Llc |
THREE METFORMIN SALT FORM
|
|
WO2014011895A2
(en)
|
2012-07-11 |
2014-01-16 |
Thetis Pharmaceuticals Llc |
High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
|
|
AU2012227298B2
(en)
|
2012-09-25 |
2015-02-12 |
Jost Chemical Co. |
Co-precipitated salts of fatty acids
|
|
TW201416726A
(zh)
|
2012-10-26 |
2014-05-01 |
Dongguan Masstop Liquid Crystal Display Co Ltd |
具有觸控功能之彩色濾光片基板
|
|
US9394318B2
(en)
|
2012-11-30 |
2016-07-19 |
Cypress Pharmaceuticals, Inc. |
Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
|
|
CN103340300A
(zh)
|
2013-06-06 |
2013-10-09 |
李才平 |
一种绿色生态鲫鱼饲料的配制方法
|
|
WO2015171516A1
(en)
*
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
|
CA2951923A1
(en)
*
|
2014-06-18 |
2015-12-23 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of active agents
|
|
US9242008B2
(en)
*
|
2014-06-18 |
2016-01-26 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of fatty acids
|
|
CN104430341B
(zh)
|
2014-12-10 |
2016-09-28 |
青岛大学 |
天然有机酸根褐藻氨酸螯合物在农用制剂中的应用
|
|
US10653703B2
(en)
|
2015-09-03 |
2020-05-19 |
Solutex Na Llc |
Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
|
|
GB201522132D0
(en)
|
2015-12-15 |
2016-01-27 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
ES2827796T3
(es)
|
2016-06-03 |
2021-05-24 |
Thetis Pharmaceuticals Llc |
Composiciones y procedimientos relativos a sales de mediadores pro-resolutivos especializados de inflamación
|